The long-term effects (10 years or more) of prostate cancer and treatment on clinical and patient-reported outcomes are not well understood. Furthermore, as patients live longer after their diagnosis, they are developing co-morbid conditions, experiencing cancer recurrences or progression and receiving secondary cancer therapies, all of which can affect their health and quality of life. A better understanding of these clinical events and their effects is essential to designing interventions to improve quality of life and for informing newly-diagnosed patients. We propose to use an existing and unique resource to improve our understanding of prostate cancer survivorship: the Prostate Cancer Outcomes Study (PCOS). The PCOS is a population-based cohort of men with prostate cancer followed longitudinally since their diagnosis in 1994-5. The dataset includes clinical and sociodemographic data, information on treatment and health-related quality of life (HRQOL) outcomes. The proposed study has the following three aims: 1) To characterize long-term (10-15 year) clinical outcomes, including biochemical recurrence (prostate-specific antigen), clinical disease progression, use of secondary cancer therapies and the onset or worsening of co-morbid illnesses and/or skeletal related events in a population-based cohort of prostate cancer survivors. 2) To assess the associations between these clinical outcomes and long-term disease-specific and general HRQOL. 3) To assess the independent associations of race/ethnicity and socioeconomic status (SES) with long- term clinical and HRQOL outcomes. To achieve these aims, we will collect 14-year data on disease recurrence/progression, receipt of secondary therapy, co-morbidity (including skeletal related and cardiovascular events), medication use, functional status and HRQOL in the surviving members of the PCOS cohort. The current PCOS cohort includes 2,348 men with prostate cancer from 6 SEER registries who have been followed since diagnosis with patient- reported data collected at 6,12, 24 and 60 months. Descriptive statistics will be used to achieve the first aim. For the second and third aims, appropriate multivariable statistical methodology will be used. When completed, this study will be the longest population-based prospective follow-up of prostate cancer survivors yet reported in the literature and will provide important information for prostate cancer survivors, clinicians, researchers and healthcare policy makers. Specifically, it will help newly-diagnosed patients make more informed decisions regarding treatment and will help researchers design novel interventions to improve the quality of life of prostate cancer survivors. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA114524-01A2
Application #
7315908
Study Section
Health Services Organization and Delivery Study Section (HSOD)
Program Officer
Potosky, Arnold L
Project Start
2007-08-01
Project End
2010-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
1
Fiscal Year
2007
Total Cost
$563,627
Indirect Cost
Name
University of Southern California
Department
Urology
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Eifler, J B; Alvarez, J; Koyama, T et al. (2017) More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades. J Urol 197:614-620
Lang, Maximilian F; Tyson, Mark D; Alvarez, JoAnn Rudd et al. (2017) The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort. Urology 103:173-178
Kent, Matthew; Penson, David F; Albertsen, Peter C et al. (2016) Successful external validation of a model to predict other cause mortality in localized prostate cancer. BMC Med 14:25
O'Neil, Brock; Koyama, Tatsuki; Alvarez, JoAnn et al. (2016) The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples. J Urol 195:321-9
Resnick, Matthew J; Barocas, Daniel A; Morgans, Alicia K et al. (2015) The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol 67:1019-1025
Morgans, Alicia K; Fan, Kang-Hsien; Koyama, Tatsuki et al. (2015) Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy. J Urol 193:1226-31
Hoffman, Richard M; Koyama, Tatsuki; Albertsen, Peter C et al. (2015) Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. J Gen Intern Med 30:924-34
Daskivich, Timothy J; Fan, Kang-Hsien; Koyama, Tatsuki et al. (2015) Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study. Urology 85:92-100
Morgans, A K; Fan, K-H; Koyama, T et al. (2014) Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study. Prostate Cancer Prostatic Dis 17:338-42
Daskivich, Timothy J; Fan, Kang-Hsien; Koyama, Tatsuki et al. (2013) Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 158:709-17

Showing the most recent 10 out of 19 publications